Juno Therapeutics Shares Sky Rocket Following Buyout For $9 Billion By: TalkMarkets January 22, 2018 at 14:36 PM EST shares of Juno Therapeutics sky rocketed on news that they were going to be bought out by Celgene Corp for $9 billion or $87 per share. Read More >> Related Stocks: Celgene Corp